Literature DB >> 28218741

Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing.

Sankhiros Babapoor1, Rong Wu2, James Kozubek1, Donna Auidi3, Jane M Grant-Kels3, Soheil S Dadras1,3.   

Abstract

A comprehensive repertoire of human microRNAs (miRNAs) that could be involved in early melanoma invasion into the dermis remains unknown. To this end, we sequenced small RNAs (18-30 nucleotides) isolated from an annotated series of invasive melanomas (average invasive depth, 2.0 mm), common melanocytic nevi, and matched normal skin (n=28). Our previously established bioinformatics pipeline identified 765 distinct mature known miRNAs and defined a set of top 40 list that clearly segregated melanomas into thin (0.75 mm) and thick (2.7 mm) groups. Among the top, miR-21-5p, let-7b-5p, let-7a-5p, miR-424-5p, miR-423-5p, miR-21-3p, miR-199b-5p, miR-182-5p, and miR-205-5p were differentially expressed between thin and thick melanomas. In a validation cohort (n=167), measured expression of miR-21-5p and miR-424-5p, not previously reported in melanoma, were significantly increased in invasive compared with in situ melanomas (P<0.0001). Increased miR-21-5p levels were significantly associated with invasive depth (P=0.038), tumor mitotic index (P=0.038), lymphovascular invasion (P=0.0036), and AJCC stage (P=0.038). In contrast, let-7b levels were significantly decreased in invasive and in situ melanomas compared with common and dysplastic nevi (P<0.0001). Decreased let-7b levels were significantly associated with invasive depth (P=0.011), Clark's level (P=0.013), ulceration (P=0.0043), and AJCC stage (P=0.011). These results define a distinct set of miRNAs associated with invasive and aggressive melanoma phenotype.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28218741     DOI: 10.1038/labinvest.2017.5

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  39 in total

1.  A microRNA cluster as a target of genomic amplification in malignant lymphoma.

Authors:  H Tagawa; M Seto
Journal:  Leukemia       Date:  2005-11       Impact factor: 11.528

Review 2.  MicroRNAs in skin response to UV radiation.

Authors:  Deeba N Syed; Mohammad Imran Khan; Maria Shabbir; Hasan Mukhtar
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

3.  Signatures of microRNAs and selected microRNA target genes in human melanoma.

Authors:  Demetra Philippidou; Martina Schmitt; Dirk Moser; Christiane Margue; Petr V Nazarov; Arnaud Muller; Laurent Vallar; Dorothee Nashan; Iris Behrmann; Stephanie Kreis
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

4.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Histology-specific microRNA alterations in melanoma.

Authors:  Laura Poliseno; Adele Haimovic; Miguel F Segura; Douglas Hanniford; Paul J Christos; Farbod Darvishian; Jinhua Wang; Richard L Shapiro; Anna C Pavlick; Russell S Berman; Eva Hernando; Jiri Zavadil; Iman Osman
Journal:  J Invest Dermatol       Date:  2012-05-03       Impact factor: 8.551

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.

Authors:  Daniel W Mueller; Michael Rehli; Anja K Bosserhoff
Journal:  J Invest Dermatol       Date:  2009-02-12       Impact factor: 8.551

8.  The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Authors:  Joseph Mazar; Katherine DeYoung; Divya Khaitan; Edward Meister; Alvin Almodovar; James Goydos; Animesh Ray; Ranjan J Perera
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

9.  Regulation of cancer aggressive features in melanoma cells by microRNAs.

Authors:  Eyal Greenberg; Liat Hershkovitz; Orit Itzhaki; Steven Hajdu; Yael Nemlich; Rona Ortenberg; Nir Gefen; Liat Edry; Shira Modai; Yona Keisari; Michal J Besser; Jacob Schachter; Noam Shomron; Gal Markel
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

10.  A novel miR-451a isomiR, associated with amelanotypic phenotype, acts as a tumor suppressor in melanoma by retarding cell migration and invasion.

Authors:  Sankhiros Babapoor; Elizabeth Fleming; Rong Wu; Soheil S Dadras
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

View more
  19 in total

Review 1.  MicroRNA heterogeneity in melanoma progression.

Authors:  Anita Thyagarajan; Kenneth Y Tsai; Ravi P Sahu
Journal:  Semin Cancer Biol       Date:  2019-06-01       Impact factor: 15.707

2.  The downregulation of putative anticancer target BORIS/CTCFL in an addicted myeloid cancer cell line modulates the expression of multiple protein coding and ncRNA genes.

Authors:  Evgeny Teplyakov; Qiongfang Wu; Jian Liu; Elena M Pugacheva; Dmitry Loukinov; Abdelhalim Boukaba; Victor Lobanenkov; Alexander Strunnikov
Journal:  Oncotarget       Date:  2017-09-02

3.  The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.

Authors:  Katherine Quiohilag; Peter Caie; Anca Oniscu; Thomas Brenn; David Harrison
Journal:  Virchows Arch       Date:  2020-05-09       Impact factor: 4.064

4.  MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis.

Authors:  Yan Wu; Liu Liu; Chunxiang Bian; Qingchun Diao; Muhammad Farrukh Nisar; Xuemei Jiang; Jörg W Bartsch; Maojiao Zhong; Xiangyu Hu; Julia Li Zhong
Journal:  Cell Commun Signal       Date:  2018-09-15       Impact factor: 5.712

5.  NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.

Authors:  Mari Hämäläinen; Hanna-Riikka Teppo; Sini Skarp; Kirsi-Maria Haapasaari; Katja Porvari; Katri Vuopala; Thomas Kietzmann; Peeter Karihtala
Journal:  Oxid Med Cell Longev       Date:  2019-09-04       Impact factor: 6.543

6.  Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma.

Authors:  Kathleen Watt; Kathrin Tyryshkin; Neil Renwick; Andrew W B Craig
Journal:  Transl Oncol       Date:  2020-05-28       Impact factor: 4.243

7.  MicroRNA Ratios Distinguish Melanomas from Nevi.

Authors:  Rodrigo Torres; Ursula E Lang; Miroslav Hejna; Samuel J Shelton; Nancy M Joseph; A Hunter Shain; Iwei Yeh; Maria L Wei; Michael C Oldham; Boris C Bastian; Robert L Judson-Torres
Journal:  J Invest Dermatol       Date:  2019-09-30       Impact factor: 8.551

8.  miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients.

Authors:  Adriana Taveira da Cruz; Aline Hunger; Fabiana Henriques Machado de Melo; Ana Carolina Monteiro; Geneviève Catherine Paré; Dulce Lai; Débora Kristina Alves-Fernandes; Ana Luisa Pedroso Ayub; Esteban Mauricio Cordero; José Franco da Silveira Filho; Regine Schneider-Stock; Bryan Eric Strauss; Victor Tron; Miriam Galvonas Jasiulionis
Journal:  Neoplasia       Date:  2021-07-08       Impact factor: 5.715

9.  miR-21-5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C.

Authors:  Zhaohui Yang; Bo Liao; Xiaoyan Xiang; Sha Ke
Journal:  FEBS Open Bio       Date:  2020-03-24       Impact factor: 2.693

Review 10.  Dissimilar Appearances Are Deceptive-Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma.

Authors:  Lisa Linck-Paulus; Claus Hellerbrand; Anja K Bosserhoff; Peter Dietrich
Journal:  Cells       Date:  2020-01-02       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.